Ezgi Bakircioglu Duman

Ezgi Bakircioglu Duman

Auto-generated profile, based on publicly available information

Ezgi Bakircioglu Duman

Univ Hlth Sci Turkey, Istanbul Haseki Training & Res Hosp, Clin Neurol, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2019 in Case Reports in Neurology
Verified
Journal Article
Open access
PDF file
EBEzgi Bakırcıoğlu-Duman
Ezgi Bakırcıoğlu-Duman
ZAZeynep Acar
Zeynep Acar
Gülçin Benbir ŞenelGülçin Benbir Şenel
Gülçin Benbir Şenel
HYHande Yüceer
Hande Yüceer
HAHürtan Acar
Hürtan Acar
ETErdem Tüzün
Erdem Tüzün
Morvan syndrome (MoS) is typically characterized by neuromyotonia, sleep dysfunction, dysautonomia, and cognitive dysfunction. However, MoS patients with mild peripheral nerve hyperexcitability (PNH) or encephalopathy features have been described. A 46-year-old woman presented with a 2-month history of constipation, hyperhidrosis, and insomnia. Neurologic examination revealed muscle twitching and needle electromyography showed myokymic discharges in all limbs. No clinical or electrophysiological features of neuromyotonia were present. Although the patient denied any cognitive symptoms, neuropsychological assessment revealed executive dysfunction, while other cognitive domains were preserved. Cranial and spinal MRIs were unrevealing and tumor investigation proved negative. Polysomnography examination revealed total insomnia, which was partially reversed upon immune-modulatory therapy. Investigation of a broad panel of antibodies revealed serum leucine-rich glioma inactivated protein 1 and contactin-associated protein 2 antibodies. The features of this case indicate that the presentation of PNH syndromes may show significant variability and that MoS patients may not necessarily exhibit full-scale PNH and encephalopathy symptoms.